Although the loss of CDKN2A and PTEN expressions is observed in various tumor types, it is thought to play a pivotal role in the pathogenesis of chordomas, with PTEN potentially serving as a prognostic and predictive biomarker [46,47]. The gene discussed is PTEN; the disease is neoplasm.